Novavax has announced the first emergency use authorization of its COVID-19 vaccine for adolescents aged 12-18 years in India. An official statement...
“Pune`s Bharati Vidyapeeth Medical College Hospital began phase 2/3 trials of Covovax in children between 7 and 11 years of age on...